Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors

Published:2014-01 Issue:1 Volume:22 Page:358-365
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Tan Qiu,Zhang Zhitao,Hui Jie,Zhao Yu,Zhu Li

Funder

Natural Science Foundation of Jiangsu Province

Natural Science Foundation of Nantong City

Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. Histone deacetylase inhibitors: molecular mechanisms of action

2. Anticancer activities of histone deacetylase inhibitors

3. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

4. Histone deacetylase inhibitors – a new tool to treat cancer

5. The role of histone deacetylases (HDACs) in human cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One‐Pot Three‐Component Construction of 2,4‐Diarylbenzo[4,5] thieno[3,2‐d] pyrimidines Using Elemental Sulfur as a Sulfur Source;ChemistrySelect;2024-06-18

2. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

3. Harnessing pyrimidine as a building block for histone deacetylase inhibitors;Archiv der Pharmazie;2023-07-18

4. Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines on the Basis of pyrano[3,4-c]pyridines;Molecules;2022-05-24

5. A Comprehensive Study of Pyrimidine and Its Medicinal Applications;HETEROCYCLES;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3